Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bavarian Nordic ADR (BVNRY)

Bavarian Nordic ADR (BVNRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,922,737
  • Shares Outstanding, K 236,499
  • Annual Sales, $ 1,025 M
  • Annual Income, $ 214,200 K
  • EBIT $ 105 M
  • EBITDA $ 266 M
  • 60-Month Beta 1.71
  • Price/Sales 2.19
  • Price/Cash Flow 4.86
  • Price/Book 1.48
  • Price/Earnings ttm 12.00
  • Earnings Per Share ttm 0.79
  • Most Recent Earnings $0.16 on 08/22/24
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.17
  • Number of Estimates 1
  • High Estimate 0.17
  • Low Estimate 0.17
  • Prior Year 0.56
  • Growth Rate Est. (year over year) -69.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.8900 +3.04%
on 11/15/24
10.8375 -24.98%
on 10/24/24
-2.0500 (-20.14%)
since 10/15/24
3-Month
7.8900 +3.04%
on 11/15/24
14.6000 -44.32%
on 08/16/24
-4.0200 (-33.09%)
since 08/15/24
52-Week
6.8412 +18.84%
on 11/16/23
14.6000 -44.32%
on 08/16/24
+0.8100 (+11.07%)
since 11/15/23

Most Recent Stories

More News
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination

Markets sent a clear message Friday following President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS). Vaccine stocks took a nosedive,...

CMPS : 5.04 (+3.07%)
PSIL : 12.58 (+0.80%)
ATAI : 1.6100 (+17.52%)
AZN : 63.23 (-2.78%)
BVNRY : 8.1300 (-14.24%)
NVAX : 7.32 (+1.39%)
MRNA : 36.85 (-7.34%)
CYBN : 11.60 (+5.45%)
GSK : 33.35 (-1.91%)
PFE : 24.80 (-4.69%)
BNTX : 99.72 (-3.71%)
SNY : 47.97 (+0.31%)
These 3 Companies Are Taking on Monkeypox

A vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.

BVNRY : 8.1300 (-14.24%)
PFE : 24.80 (-4.69%)
SIGA : 5.94 (-5.71%)
DGX : 160.44 (+2.30%)
LH : 235.21 (-1.25%)
What Monkeypox Could Mean for These 2 Stocks?

Vaccine companies saw stock prices spike during the COVID pandemic. The same could happen amid a new outbreak.

PFE : 24.80 (-4.69%)
BVNRY : 8.1300 (-14.24%)
SIGA : 5.94 (-5.71%)
Are These 4 Stocks Smart Buys With the Monkeypox Outbreak?

The monkeypox opportunity could already be baked into the prices of these stocks.

BVNRY : 8.1300 (-14.24%)
SIGA : 5.94 (-5.71%)
CMRX : 0.8599 (-4.32%)
EBS : 7.72 (-16.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company's product pipeline consists of IMVAMUNE(R), PROSTVAC (R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical...

See More

Key Turning Points

3rd Resistance Point 8.4833
2nd Resistance Point 8.3167
1st Resistance Point 8.2233
Last Price 8.1300
1st Support Level 7.9633
2nd Support Level 7.7967
3rd Support Level 7.7033

See More

52-Week High 14.6000
Fibonacci 61.8% 11.6361
Fibonacci 50% 10.7206
Fibonacci 38.2% 9.8051
Last Price 8.1300
52-Week Low 6.8412

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar